Los Angeles, California - Brain imaging may accurately identify patients likely to benefit from stroke clot removal instead of relying on the time since symptoms began as an indicator of treatment eligibility, according to research presented at the American Stroke Association’s International Stroke Conference 2016.

Dallas, Texas - Keeping your pressure under control can mean adding things to your life, like exercise, that help lower it. But, you may not realize that it also means avoiding things that raise your pressure. A healthy blood pressure level means you’re less likely to have a heart attack or stroke.

Chicago, Illinois - The American Medical Association today released the findings of a national physician survey that shows strong support for key policies and recommendations to end the nation’s opioid epidemic, including ways to improve prescription drug monitoring programs, enhancing physician education as well as removing barriers to care.

Los Angeles, California - Pioglitazone, a drug used for type 2 diabetes, may prevent recurrent stroke and heart attacks in people with insulin resistance but without diabetes. The results of the Insulin Resistance Intervention after Stroke (IRIS) trial, presented at the International Stroke Conference 2016 in Los Angeles and published in the New England Journal of Medicine, suggest a potential new method to prevent stroke and heart attack in high-risk patients who have already had one stroke or transient ischemic attack. 

Washington, DC - The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16 years and older with epilepsy.

Washington, DC - On February 29, NIH will host a Rare Disease Day event to raise awareness about rare diseases, the people they affect and current research collaborations. An estimated 25 million people in the United States have rare diseases. The event will feature presentations, posters, exhibits, an art show and tours of the NIH Clinical Center - a hospital at which researchers are studying nearly 600 rare diseases in partnership with over 15,000 patients. Admission is free and open to the public.